Taking on analysts’ expectations and winning: Quince Therapeutics Inc (QNCX)

With 5.63 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.22 million shares. The 52-week range on QNCX shows that it touched its highest point at $2.45 and its lowest point at $0.51 during that stretch. It currently has a 1-year price target of $7.25. Beta for the stock currently stands at 0.83.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of QNCX was down-trending over the past week, with a drop of -3.80%, but this was down by -13.49% over a month. Three-month performance dropped to -31.87% while six-month performance fell -16.79%. The stock gained 9.72% in the past year, while it has lost -41.71% so far this year. A look at the trailing 12-month EPS for QNCX yields -1.31 with Next year EPS estimates of -0.68. For the next quarter, that number is -0.23. This implies an EPS growth rate of 40.08% for this year and 13.06% for next year. EPS is expected to grow by 33.51% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 7.53%.

Float and Shares Shorts:

At present, 44.00 million QNCX shares are outstanding with a float of 32.75 million shares on hand for trading.

An Overview of Recent Financials:

Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. The EBITDA in the recently reported quarter was -$8190000.0 and diluted EPS was $nan.

Analysts Ratings:

In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$1.216 being high and -$1.216 being low. For QNCX, this leads to a yearly average estimate of -$1.216.